Ajinomoto has completed the acquisition of Althea Technologies, a provider of biopharmaceutical development and manufacturing services.
Subscribe to our email newsletter
All the capital stock of Althea is purchased by Ajinomoto at closing for approximately $175m.
Althea will turn out to be a fully consolidated subsidiary of Ajinomoto, doing business as Ajinomoto Althea.
Ajinomoto manufactures pharmaceuticals, specialty chemicals, seasonings, processed foods, beverages and amino acids.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.